Mass Spectrometry Market Size To Reach $10.65 Billion By 2030

Mass Spectrometry Market Growth & Trends

The global mass spectrometry market size is expected to reach USD 10.65 billion by 2030, registering a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness regarding early detection of chronic and infectious diseases and emerging technological advancements in diagnostic instruments are expected to significantly drive the market growth. In addition, there has been an increase in demand for cost-effective and automated techniques for disease diagnosis which is anticipated to increase the demand for mass spectrometry techniques and positively affect the growth.

The COVID-19 pandemic has boosted the demand for vaccine development due to recent advancements in virology-based research. Here, mass spectrometry has applications for the study of viral structure for SARS-CoV-2. The technique can also be used to study complex protein structures and protein-protein interactions associated with the virus. Hence, various pharmaceutical and biotechnology companies involved in COVID-19 vaccine and drug development efforts are anticipated to increase the demand for instruments and consumables.

In addition, various academic institutions and companies are indulging in product development strategies to support the demand for mass spectrometry from the proteomic market. For instance, in September 2022, the director of Northwestern’s Proteomics Center of Excellence published a paper on the development of a new imaging approach to enhance the identification of intact proteoforms. The team of researchers has built a Proteoform Imaging Mass Spectrometry (PiMS) system which is anticipated to assist mass spectrometry in various applications, including the detection of novel biomarkers, mapping of molecular tissue, and improvement in disease diagnosis.

Similarly, in October 2022, Thermo Fisher Scientific, Inc. announced the launch of mass spectrometry consumables and instrument that allows end-users in proteomics and biopharma to achieve significant breakthroughs. The instrument, known as Thermo Scientific Orbitrap Ascend Tribrid mass spectrometer, provides a new capability to direct multiple ions and enables to gain deeper insights into samples, along with rapid detection.

 Request a free sample copy or view report summary: Mass Spectrometry Market Report

Mass Spectrometry Market Report Highlights

• The instruments segment dominated the market with the largest revenue share and is expected to grow at a significant CAGR of 7.28% over the forecast period due to the presence of a large number of companies offering different types of mass spectrometry instruments.

• Quadrupole Liquid Chromatography-Mass Spectrometry dominated the market with the largest share of 37.3% in 2024.

• The proteomics segment held the largest market share of 46.21% in 2024. Mass spectrometry-based proteomics research is a comprehensive technique for quantitative profiling of proteins and studying protein-protein interactions.

• The pharmaceutical and biotechnology companies segment dominated the market in 2024 due to the extensive adoption of protein sequencing using mass spectrometry in the pharmaceutical industry for drug discovery and development processes.

• The North America mass spectrometry market dominated globally in 2024 with a revenue share of 41.63%. This large share is due to the presence of key market players, established academic institutions, pharmaceutical companies, and research centers, coupled with robust funding opportunities for R&D in biotechnology and drug discovery & development.

Mass Spectrometry Market Segmentation

Grand View Research has segmented global mass spectrometry market report based on product, technology, application, end-use, and region:

Mass Spectrometry Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Consumables & Services

Mass Spectrometry Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Quadrupole Liquid Chromatography-Mass Spectrometry

• Gas Chromatography-Mass Spectrometry (GC-MS)

• Fourier Transform-Mass Spectrometry (FT-MS)

• Time-of-Flight Mass Spectrometry (TOFMS)

• Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF)

• Magnetic Sector Mass Spectrometry

• Others

Mass Spectrometry Application Outlook (Revenue, USD Million, 2018 - 2030)

• Proteomics     

• Metabolomics

• Glycomics      

• Others

Mass Spectrometry End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Government & Academic Institutions

• Pharmaceutical & Biotechnology Companies

• Others

Mass Spectrometry Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Mass Spectrometry Market

• Thermo Fisher Scientific, Inc.

• Agilent Technologies, Inc.

• Danaher Corporation (SCIEX)

• Waters Corporation

• Bruker Corporation

• Shimadzu Corporation

• PerkinElmer, Inc.

• Rigaku Corporation

• LECO Corporation

• JEOL Ltd.